BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7609083)

  • 1. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D.
    Mattion NM; Reilly PA; Camposano E; Wu SL; DiMichele SJ; Ishizaka ST; Fantini SE; Crowley JC; Weeks-Levy C
    J Virol; 1995 Aug; 69(8):5132-7. PubMed ID: 7609083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.
    Mattion NM; Reilly PA; DiMichele SJ; Crowley JC; Weeks-Levy C
    J Virol; 1994 Jun; 68(6):3925-33. PubMed ID: 8189529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice.
    Yim TJ; Tang S; Andino R
    Virology; 1996 Apr; 218(1):61-70. PubMed ID: 8615042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity.
    Tang S; van Rij R; Silvera D; Andino R
    J Virol; 1997 Oct; 71(10):7841-50. PubMed ID: 9311872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence.
    Marc D; Drugeon G; Haenni AL; Girard M; van der Werf S
    EMBO J; 1989 Sep; 8(9):2661-8. PubMed ID: 2555183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins.
    Moldoveanu Z; Porter DC; Lu A; McPherson S; Morrow CD
    Vaccine; 1995 Aug; 13(11):1013-22. PubMed ID: 8525684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
    Porter DC; Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristylation of picornavirus capsid protein VP4 and its structural significance.
    Chow M; Newman JF; Filman D; Hogle JM; Rowlands DJ; Brown F
    Nature; 1987 Jun 11-17; 327(6122):482-6. PubMed ID: 3035380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
    Marc D; Masson G; Girard M; van der Werf S
    J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
    Kräusslich HG; Hölscher C; Reuer Q; Harber J; Wimmer E
    J Virol; 1990 May; 64(5):2433-6. PubMed ID: 2157900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins.
    Prange R; Clemen A; Streeck RE
    J Virol; 1991 Jul; 65(7):3919-23. PubMed ID: 2041101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.
    Moscufo N; Chow M
    J Virol; 1992 Dec; 66(12):6849-57. PubMed ID: 1331497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant polioviruses expressing hepatitis B virus-specific cytotoxic T-lymphocyte epitopes.
    Cho SP; Lee B; Min MK
    Vaccine; 2000 Jun; 18(25):2878-85. PubMed ID: 10812231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An NH2-terminal peptide from the vaccinia virus L1R protein directs the myristylation and virion envelope localization of a heterologous fusion protein.
    Ravanello MP; Franke CA; Hruby DE
    J Biol Chem; 1993 Apr; 268(10):7585-93. PubMed ID: 8463289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myristoylation is important at multiple stages in poliovirus assembly.
    Moscufo N; Simons J; Chow M
    J Virol; 1991 May; 65(5):2372-80. PubMed ID: 1850017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capsid protein VP4 of poliovirus is N-myristoylated.
    Paul AV; Schultz A; Pincus SE; Oroszlan S; Wimmer E
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7827-31. PubMed ID: 2825164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.
    Porter DC; Melsen LR; Compans RW; Morrow CD
    J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.